BankInvest, the Danish asset management house, has invested in Ark Therapeutics, the Anglo-Finnish biotechnology company which raised a total of £14.5m (€23m) in its third round of fundraising.
BankInvest led the financing round alongside investors that include Merlin Biosciences and Nomura International.